Greece liking life feelings habits presents Greece

3 Questions We Always Regret Not Asking Ourselves Sooner

Reading now: 640
www.marcandangel.com

The most powerful weapon against stress is our ability to choose one thought or action over another. Train yourself to see and be the good in this day.A couple thousand years ago in ancient Greece, the great philosopher Socrates was strolling contemplatively around a community garden when a neighbor walked up to him and said, “You’re never in a million years going to believe what I just heard about our mutual friend…”“Wait,” Socrates interrupted, putting his hand up in the air. “Before you continue with this story, your words must pass the triple filter test?”“The what?”“The triple filter test,” Socrates said.The neighbor just stared at him with a blank expression.Socrates continued, “The first filter is Truth.

Are you absolutely sure the story you are about to tell me is true?”“Well, no,” the neighbor said, “I literally just heard it from someone else I know.”“Ah-ha…” Socrates quickly replied, “then let’s move on to the second filter.

Is what you are about to share Good in any way, shape or form?”“No… no,” the neighbor said, “This story is actually quite…”Before he could finish his sentence, Socrates interrupted him again, “Ahh, so it may not be true and it is definitely not good.”“That’s right,” the neighbor assured him.“Well, you may still be able to save yourself,” Socrates said. “Is anything about the story you want to share Useful?”The neighbor stared blankly again for a moment and then said, “No, I suppose it’s not really…”“So, you want to tell me something that may not be true, is definitely not good, and is not useful to know?” Socrates asked.

Read more on marcandangel.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

additudemag.com
58%
117
LSD, MDMA, Magic Mushrooms Clinical Trial Guidelines Released by FDA
July 7, 2023The Food and Drug Administration (FDA) has issued its first-ever draft guidance for clinical trials of psychedelic drugs to treat conditions including depression, mood disorders, anxiety, post-traumatic stress disorder, and substance use disorder.The guidance aims to address the unique challenges inherent in testing “classic psychedelics,” such as psilocybin (magic mushrooms) and lysergic acid diethylamide (LSD), and “entactogens” or “empathogens,” such as methylenedioxymethamphetamine (MDMA) for treating psychiatric conditions that failed to respond to other therapies. The FDA recommends clinical trial considerations regarding subject safety, data collection, manufacturing controls, and drug application requirements.Ultimately, “the goal is to help researchers design studies that will yield interpretable results that will be capable of supporting future drug applications,” said Tiffany Farchione, M.D., director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research, in a statement last month.In February 2022, researchers from Johns Hopkins Medicine reported that psilocybin-assisted therapy for major depressive disorder produced antidepressant effects up to 12 months after treatment.1Ari Tuckman, Psy.D., and Stephanie Sarkis, Ph.D., recently told ADDitude that using very low (micro) doses of psychedelics, such as LSD and psilocybin is gaining renewed attention as a treatment for anxiety and depression.
DMCA